Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hemangiosarcoma × 30 days × Clear all

Phase

Status

Recruiting 5 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 80 Neoplasms 64 Prostatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 31 Melanoma 27 Colorectal Neoplasms 22 Brain Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Neoplasm Metastasis 15 Lung Neoplasms 15 Pancreatic Neoplasms 13 Ovarian Neoplasms 13 Multiple Myeloma 13 Head and Neck Neoplasms 13 Uterine Cervical Neoplasms 12 Sarcoma 12 Glioma 12 Urinary Bladder Neoplasms 11 Recurrence 11 Colonic Neoplasms 11 Carcinoma, Hepatocellular 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Hematologic Neoplasms 10 Esophageal Neoplasms 10 Lymphoma, Follicular 9 Lymphoma 9 Leukemia, Myeloid, Acute 9 Stomach Neoplasms 8 Leukemia 8 Hodgkin Disease 8

Interventions

Paclitaxel 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01303497 2026-03-13

ANGIO-TAX+

Centre Oscar Lambret

Phase 2 Completed

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡